[Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000652:urine; D004298:Dopamine / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000652:urine; D014642:Vanilmandelic Acid / Q000652:urine
D010648:Phenylacetates; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine